[English] 日本語
Yorodumi- PDB-3zt4: Small molecule inhibitors of the LEDGF site of HIV type 1 integra... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 3zt4 | ||||||
|---|---|---|---|---|---|---|---|
| Title | Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by fragment screening and structure based drug design | ||||||
Components | INTEGRASE | ||||||
Keywords | TRANSFERASE / AIDS | ||||||
| Function / homology | Function and homology informationHIV-1 retropepsin / symbiont-mediated activation of host apoptosis / retroviral ribonuclease H / exoribonuclease H / exoribonuclease H activity / host multivesicular body / DNA integration / viral genome integration into host DNA / RNA-directed DNA polymerase / establishment of integrated proviral latency ...HIV-1 retropepsin / symbiont-mediated activation of host apoptosis / retroviral ribonuclease H / exoribonuclease H / exoribonuclease H activity / host multivesicular body / DNA integration / viral genome integration into host DNA / RNA-directed DNA polymerase / establishment of integrated proviral latency / viral penetration into host nucleus / RNA stem-loop binding / RNA-directed DNA polymerase activity / RNA-DNA hybrid ribonuclease activity / Transferases; Transferring phosphorus-containing groups; Nucleotidyltransferases / host cell / viral nucleocapsid / endonuclease activity / DNA recombination / DNA-directed DNA polymerase / aspartic-type endopeptidase activity / Hydrolases; Acting on ester bonds / DNA-directed DNA polymerase activity / symbiont-mediated suppression of host gene expression / viral translational frameshifting / lipid binding / symbiont entry into host cell / host cell nucleus / host cell plasma membrane / virion membrane / structural molecule activity / proteolysis / DNA binding / zinc ion binding / membrane Similarity search - Function | ||||||
| Biological species | ![]() HUMAN IMMUNODEFICIENCY VIRUS | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.2 Å | ||||||
Authors | Peat, T.S. / Newman, J. / Rhodes, D.I. / Vandergraaff, N. / Le, G. / Jones, E.D. / Smith, J.A. / Coates, J.A.V. / Thienthong, N. / Dolezal, O. ...Peat, T.S. / Newman, J. / Rhodes, D.I. / Vandergraaff, N. / Le, G. / Jones, E.D. / Smith, J.A. / Coates, J.A.V. / Thienthong, N. / Dolezal, O. / Ryan, J.H. / Savage, G.P. / Francis, C. / Deadman, J.J. | ||||||
Citation | Journal: Plos One / Year: 2012Title: Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design Authors: Peat, T.S. / Rhodes, D.I. / Vandergraaff, N. / Le, G. / Smith, J.A. / Clark, L.J. / Jones, E.D. / Coates, J.A.V. / Thienthong, N. / Newman, J. / Dolezal, O. / Mulder, R. / Ryan, J.H. / ...Authors: Peat, T.S. / Rhodes, D.I. / Vandergraaff, N. / Le, G. / Smith, J.A. / Clark, L.J. / Jones, E.D. / Coates, J.A.V. / Thienthong, N. / Newman, J. / Dolezal, O. / Mulder, R. / Ryan, J.H. / Savage, G.P. / Francis, C.L. / Deadman, J.J. #1: Journal: Antivir.Chem.Chemother. / Year: 2011Title: Structural Basis for a New Mechanism of Inhibition of HIV-1 Integrase Identified by Fragment Screening and Structure-Based Design. Authors: Rhodes, D.I. / Peat, T.S. / Vandegraaff, N. / Jeevarajah, D. / Le, G. / Jones, E.D. / Smith, J.A. / Coates, J.A. / Winfield, L.J. / Thienthong, N. / Newman, J. / Lucent, D. / Ryan, J.H. / ...Authors: Rhodes, D.I. / Peat, T.S. / Vandegraaff, N. / Jeevarajah, D. / Le, G. / Jones, E.D. / Smith, J.A. / Coates, J.A. / Winfield, L.J. / Thienthong, N. / Newman, J. / Lucent, D. / Ryan, J.H. / Savage, G.P. / Francis, C.L. / Deadman, J.J. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 3zt4.cif.gz | 81.1 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb3zt4.ent.gz | 61 KB | Display | PDB format |
| PDBx/mmJSON format | 3zt4.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 3zt4_validation.pdf.gz | 1.8 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 3zt4_full_validation.pdf.gz | 1.8 MB | Display | |
| Data in XML | 3zt4_validation.xml.gz | 16.3 KB | Display | |
| Data in CIF | 3zt4_validation.cif.gz | 21.7 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/zt/3zt4 ftp://data.pdbj.org/pub/pdb/validation_reports/zt/3zt4 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 3zcmC ![]() 3zsoC ![]() 3zsqC ![]() 3zsrC ![]() 3zsvC ![]() 3zswC ![]() 3zsxC ![]() 3zsyC ![]() 3zszC ![]() 3zt0C ![]() 3zt1C ![]() 3zt2C ![]() 3zt3C ![]() 3nf7S C: citing same article ( S: Starting model for refinement |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
-Protein , 1 types, 2 molecules AB
| #1: Protein | Mass: 18395.842 Da / Num. of mol.: 2 / Fragment: CORE CATALYTIC DOMAIN, RESIDUES 56-212 / Mutation: YES Source method: isolated from a genetically manipulated source Details: INHIBITOR BOUND TO THE LEDGF SITE / Source: (gene. exp.) ![]() HUMAN IMMUNODEFICIENCY VIRUS / Strain: TYPE 1 / Production host: ![]() References: UniProt: Q76353, UniProt: P12497*PLUS, Transferases; Transferring phosphorus-containing groups; Nucleotidyltransferases |
|---|
-Non-polymers , 5 types, 116 molecules 








| #2: Chemical | ChemComp-SO4 / #3: Chemical | #4: Chemical | ChemComp-EDO / | #5: Chemical | ChemComp-ZT2 / #6: Water | ChemComp-HOH / | |
|---|
-Details
| Compound details | ENGINEERED RESIDUE IN CHAIN A, CYS 56 TO SER ENGINEERED RESIDUE IN CHAIN A, PHE 139 TO ASP ...ENGINEERED |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.45 Å3/Da / Density % sol: 50 % / Description: NONE |
|---|---|
| Crystal grow | pH: 5.5 Details: THE PROTEIN WAS CONCENTRATED TO 5.5MG/ML IN 40 MM TRIS PH 8.0, 250 MM NACL, 30 MM MGCL2, 5 MM DTT AND SET UP IN A 1:1 RATIO WITH 1.6 TO 2.0 M AMMONIUM SULFATE, 100 MM SODIUM ACETATE BUFFER PH 5.0 TO 5.5. |
-Data collection
| Diffraction | Mean temperature: 100 K |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: Australian Synchrotron / Beamline: MX1 / Wavelength: 0.96 |
| Detector | Type: ADSC CCD / Detector: CCD / Date: May 1, 2008 / Details: MIRRORS |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.96 Å / Relative weight: 1 |
| Reflection | Resolution: 2.2→61.55 Å / Num. obs: 19132 / % possible obs: 100 % / Observed criterion σ(I): 1 / Redundancy: 5.7 % / Rmerge(I) obs: 0.15 / Net I/σ(I): 10.4 |
| Reflection shell | Resolution: 2.2→2.32 Å / Redundancy: 5.7 % / Rmerge(I) obs: 0.8 / Mean I/σ(I) obs: 2.1 / % possible all: 100 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: PDB ENTRY 3NF7 Resolution: 2.2→61.54 Å / Cor.coef. Fo:Fc: 0.956 / Cor.coef. Fo:Fc free: 0.919 / SU B: 5.322 / SU ML: 0.135 / Cross valid method: THROUGHOUT / ESU R: 0.229 / ESU R Free: 0.197 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 29.731 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.2→61.54 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




HUMAN IMMUNODEFICIENCY VIRUS
X-RAY DIFFRACTION
Citation

































PDBj




